Kyle Tsai

Dr. Kyle Tsai

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Journal of Urology
Verified
Journal Article
Closed access
AWAdam B. Weiner
Adam B. Weiner
KTKyle Tsai
Kyle Tsai
MKMary-Kate Keeter
Mary-Kate Keeter
DVDavid Victorson
David Victorson
ESEdward M. Schaeffer
Edward M. Schaeffer
SKShilajit D. Kundu
Shilajit D. Kundu
Purpose: Shared decision making is recommended in regard to prostate cancer screening. Decision aids may facilitate this process but the impact of decision aids on screening preferences is poorly u...

1 January 2025 in Therapeutic Advances in Urology
Verified
Journal Article
Open access
KTKyle Tsai
Kyle Tsai
PXPerry Xu
Perry Xu
JGJenny N. Guo
Jenny N. Guo
NDNicholas Dean
Nicholas Dean
NKNabila Khondakar
Nabila Khondakar
AKAmy Krambeck
Amy Krambeck
Objectives: To review outcomes for patients with irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD) who undergo holmium laser enucleation of prostate (HoLEP) for bothersome urinary symptoms related to benign prostatic hyperplasia (BPH). Methods: We performed a retrospective review of patients who had undergone HoLEP by a single surgeon between January 2021 and August 2023. Preoperative, intraoperative, and postoperative characteristics were compared between patients with an ICD-10 diagnosis of IBS or IBD and those without, using Chi-square and paired T -tests as appropriate. Results: Out of 918 men, 24 (2.6%) had a diagnosis of IBS, and 36 (3.9%) had a diagnosis of IBD. There were no differences in age, BMI, preoperative American Urological Association symptoms score (AUASS), preoperative Michigan Incontinence Symptom Index (MISI) score, and history of urinary retention or incontinence. The IBS + IBD cohort had smaller prostates (100.9 vs 124.2 mL, p = 0.01) and shorter procedure times (57.0 vs 66.5 min, p = 0.02) than controls. IBS patients were more likely to require anticholinergic therapy at a 3-month follow-up (31% vs 13%, p = 0.03) and had more postoperative encounters within 90 days of HoLEP (3.7 vs 2.6, p = 0.01). There were no differences regarding changes in AUASS and MISI scores, same-day trial of void and same-day discharge rates, or complication rates. Conclusion: IBS patients who underwent HoLEP had more symptomatic postoperative courses requiring higher rates of anticholinergic medication use and more provider interactions compared to men without IBS, despite similar AUASS and MISI scores. These trends were not observed in patients with IBD.

24 July 2024 in The Prostate
Verified
Journal Article
Open access
KTKyle Tsai
Kyle Tsai
PXPerry Xu
Perry Xu
JGJenny Guo
Jenny Guo
NDNicholas Dean
Nicholas Dean
NKNabila Khondakar
Nabila Khondakar
AKAmy Krambeck
Amy Krambeck
Introduction and Objectives: Prostate magnetic resonance imaging (MRI) is used for prostate cancer (PCa) screening and risk stratification and is helpful for surgical planning for patients undergoing holmium laser enucleation of the prostate (HoLEP). There are few studies investigating the correlation between MRI Prostate Imaging‐Reporting and Data System (PIRADS) lesion characteristics and HoLEP pathology and outcomes.Methods: We performed retrospective review of patients who underwent HoLEP between January 2021 and August 2023 by a single surgeon. Preoperative, intraoperative, and postoperative characteristics and outcomes were analyzed for all patients who had a documented preoperative prostate MRI.Results: There were 334 patients without a pre‐existing diagnosis of PCa and with a preoperative prostate MRI, of which 140 (42%) had at least one PIRADS lesion. There was a total of 203 PIRADS lesions: 91 (45%) in the peripheral zone (PZ), 106 (52%) in the transition zone (TZ), and 6 (2%) not specified. Incidental PCa was noted in 44 (13%) patients at time of HoLEP. Presence or location of lesion was not significantly associated with rate or grade of incidental PCa on pathology. Greater number of lesions and lesion size correlated with longer procedure times. Lesion number, size, or grade were not found to correlate with cancer grade or rate of cancer.Conclusions: Grade, presence, location, size, and number of PIRADS lesions on preoperative prostate MRI for patients with an appropriate prior PCa workup were not significantly associated with incidental PCa or higher PCa grade on HoLEP pathology.

Verified
Journal Article
Open access
PDF file
KTKyle Tsai
Kyle Tsai
NKNabila Reem Khondakar
Nabila Reem Khondakar
APAmir Shahreza Patel
Amir Shahreza Patel
JGJenny N. Guo
Jenny N. Guo
NGNathan Gill
Nathan Gill
AKAmy E. Krambeck
Amy E. Krambeck
Background/Objectives: Variations in urinary symptom improvement after benign prostatic hyperplasia (BPH) surgery remain incompletely characterized. Preoperative factors, including bowel dysfunction, may influence postoperative recovery. We evaluated the association between baseline bowel function and urinary outcomes after holmium laser enucleation of the prostate (HoLEP), hypothesizing that worse baseline constipation would be associated with poorer outcomes. Methods: A prospective cohort study of patients undergoing HoLEP by a single surgeon at a high-volume center (December 2023–September 2024) was performed. Patients with neurogenic bladders, bowel disorders, or diabetes mellitus were excluded. Baseline bowel function was assessed using the Constipation Scoring System (CSS) and Vaizey Incontinence Score (VIS). The primary outcomes were 3-month changes in International Prostate Symptom Score (IPSS) and Michigan Incontinence Severity Index (MISI). Associations were evaluated using Spearman correlation and multivariable linear regression. Results: Among 102 patients (median age of 71.6 years), 81 (79.4%) completed follow-up. The median prostate size was 90.5 cc, and 50% had prior urinary retention. The baseline CSS and VIS were low. IPSS, quality of life, and MISI bother improved postoperatively, while MISI severity showed minimal change. Higher CSS correlated with higher VIS (p < 0.001). Baseline CSS and VIS were not associated with changes in IPSS, quality-of-life (QoL), or MISI bother. Baseline VIS was associated with modest improvement in MISI severity (β −1.14, p = 0.01). Conclusions: Baseline bowel function was not associated with urinary symptom improvement after HoLEP. However, preoperative fecal incontinence was associated with improvement in urinary incontinence severity.

18 August 2025 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
CWClarissa Wong
Clarissa Wong
PXPerry Xu
Perry Xu
MGMeera Ganesh
Meera Ganesh
NKNabila Reem Khondakar
Nabila Reem Khondakar
LGLuis Gago
Luis Gago
AKAmy Krambeck
Amy Krambeck

1 February 2020 in Urology
Verified
Journal Article
Closed access
KTKyle Tsai
Kyle Tsai
MHMatthew T. Hudnall
Matthew T. Hudnall
AWAdam B. Weiner
Adam B. Weiner
MKMary-Kate Keeter
Mary-Kate Keeter
JMJoshua J. Meeks
Joshua J. Meeks